The bit I read in the annual report for 22/23 referred to 45% gross profit margins in the second half vs 31% in the first half I suspect that margin has grown to 50%. I based my back of envelope breakeven numbers in approx. 12 months on that number and 40% qtr on qtr growth. I only posted that a few days ago on another thread but already it seems I undercooked the numbers.
Ann: Metagenics clarifying annoucement, page-9
Add CCO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.81M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $31.08K | 3.398M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13531401 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 11942350 | 15 |
View Market Depth
| Last trade - 12.11pm 12/09/2024 (20 minute delay) ? |
| CCO (ASX) Chart |